Display options
Cite
Wilder PT, Charpentier TH, Liriano MA, et al. In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction. Int J High Throughput Screen. 2010;2010(1):109-126doi: 10.2147/IJHTS.S8210.
Wilder, P. T., Charpentier, T. H., Liriano, M. A., Gianni, K., Varney, K. M., Pozharski, E., Coop, A., Toth, E. A., Mackerell, A. D., & Weber, D. J. (2010). In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction. International journal of high throughput screening, 2010(1), 109-126. https://doi.org/10.2147/IJHTS.S8210
Wilder, Paul T, et al. "In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction." International journal of high throughput screening vol. 2010,1 (2010): 109-126. doi: https://doi.org/10.2147/IJHTS.S8210
Wilder PT, Charpentier TH, Liriano MA, Gianni K, Varney KM, Pozharski E, Coop A, Toth EA, Mackerell AD, Weber DJ. In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction. Int J High Throughput Screen. 2010 Jul 07;2010(1):109-126. doi: 10.2147/IJHTS.S8210. PMID: 21132089; PMCID: PMC2995924.
Copy Download .nbib Format: NLM
Share it on

Int J High Throughput Screen. 2010 Jul 07;2010(1):109-126. doi: 10.2147/IJHTS.S8210.

In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction.

International journal of high throughput screening

Paul T Wilder, Thomas H Charpentier, Melissa A Liriano, Kira Gianni, Kristen M Varney, Edwin Pozharski, Andrew Coop, Eric A Toth, Alex D Mackerell, David J Weber

Affiliations

  1. Department of Biochemistry and Molecular Biology, The University of Maryland School of Medicine, Maryland, USA.

PMID: 21132089 PMCID: PMC2995924 DOI: 10.2147/IJHTS.S8210

Abstract

S100B is highly over-expressed in many cancers, including malignant melanoma. In such cancers, S100B binds wild-type p53 in a calcium-dependent manner, sequestering it, and promoting its degradation, resulting in the loss of p53-dependent tumor suppression activities. Therefore, S100B inhibitors may be able to restore wild-type p53 levels in certain cancers and provide a useful therapeutic strategy. In this regard, an automated and sensitive fluorescence polarization competition assay (FPCA) was developed and optimized to screen rapidly for lead compounds that bind Ca(2+)-loaded S100B and inhibit S100B target complex formation. A screen of 2000 compounds led to the identification of 26 putative S100B low molecular weight inhibitors. The binding of these small molecules to S100B was confirmed by nuclear magnetic resonance spectroscopy, and additional structural information was provided by x-ray crystal structures of several compounds in complexes with S100B. Notably, many of the identified inhibitors function by chemically modifying Cys84 in protein. These results validate the use of high-throughput FPCA to facilitate the identification of compounds that inhibit S100B. These lead compounds will be the subject of future optimization studies with the ultimate goal of developing a drug with therapeutic activity for the treatment of malignant melanoma and/or other cancers with elevated S100B.

References

  1. Biochem Pharmacol. 2003 Jan 1;65(1):1-8 - PubMed
  2. J Biol Chem. 2001 Sep 14;276(37):35037-41 - PubMed
  3. Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55 - PubMed
  4. Curr Top Med Chem. 2007;7(1):63-82 - PubMed
  5. J Biomol NMR. 1991 Jul;1(2):155-65 - PubMed
  6. J Magn Reson B. 1995 Jul;108(1):94-8 - PubMed
  7. Clin Cancer Res. 2003 Sep 15;9(11):4282-5 - PubMed
  8. Methods Enzymol. 1994;239:3-79 - PubMed
  9. J Biomol Screen. 1999;4(2):67-73 - PubMed
  10. J Biol Chem. 2009 May 15;284(20):13804-13811 - PubMed
  11. Chem Res Toxicol. 2008 Feb;21(2):483-93 - PubMed
  12. Biochemistry. 1989 Jul 25;28(15):6150-6 - PubMed
  13. Biochem J. 2006 Jun 1;396(2):201-14 - PubMed
  14. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11627-31 - PubMed
  15. J Chromatogr A. 2004 Oct 8;1051(1-2):135-9 - PubMed
  16. Clin Biochem. 2004 Jul;37(7):512-8 - PubMed
  17. J Biol Chem. 2001 Jun 22;276(25):22699-708 - PubMed
  18. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9367-72 - PubMed
  19. Am J Physiol Gastrointest Liver Physiol. 2003 Dec;285(6):G1335-44 - PubMed
  20. Methods Enzymol. 1997;276:307-26 - PubMed
  21. J Mol Biol. 2009 Dec 18;394(5):922-30 - PubMed
  22. J Med Chem. 2002 Apr 11;45(8):1712-22 - PubMed
  23. Biochemistry. 2005 Apr 19;44(15):5690-702 - PubMed
  24. Nucleic Acids Res. 2000 Jan 1;28(1):235-42 - PubMed
  25. Biochim Biophys Acta. 2006 Nov;1763(11):1284-97 - PubMed
  26. J Agric Food Chem. 2001 Oct;49(10):4619-26 - PubMed
  27. J Am Chem Soc. 2001 Jun 27;123(25):6108-17 - PubMed
  28. Biochem Biophys Res Commun. 2001 Sep 7;286(5):1212-7 - PubMed
  29. Trends Biochem Sci. 1988 Nov;13(11):437-43 - PubMed
  30. Acta Crystallogr D Biol Crystallogr. 2006 Jun;62(Pt 6):569-75 - PubMed
  31. J Biomol NMR. 1995 Nov;6(3):277-93 - PubMed
  32. J Mol Biol. 2010 Mar 12;396(5):1227-43 - PubMed
  33. Oncogene. 2010 Apr 8;29(14):2024-35 - PubMed
  34. J Biol Chem. 1999 Apr 9;274(15):10539-44 - PubMed
  35. Curr Opin Struct Biol. 1998 Oct;8(5):631-9 - PubMed
  36. Biochemistry. 2002 Jan 8;41(1):1-7 - PubMed
  37. Int J Biochem Cell Biol. 2009 Apr;41(4):784-90 - PubMed
  38. Acta Crystallogr D Biol Crystallogr. 2004 Oct;60(Pt 10):1833-9 - PubMed
  39. Nat Chem Biol. 2005 Aug;1(3):146-8 - PubMed
  40. J Biol Chem. 1986 Jun 25;261(18):8192-203 - PubMed
  41. Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32 - PubMed
  42. Biochemistry. 1998 Mar 3;37(9):2729-40 - PubMed
  43. J Biomol NMR. 1991 May;1(1):99-104 - PubMed
  44. Protein Sci. 1998 Mar;7(3):794-8 - PubMed
  45. J Biomol Screen. 2003 Feb;8(1):34-8 - PubMed
  46. Biochemistry. 1998 Feb 17;37(7):1951-60 - PubMed
  47. J Med Chem. 2004 Oct 7;47(21):5085-93 - PubMed
  48. Acta Crystallogr D Biol Crystallogr. 2001 Oct;57(Pt 10):1451-6 - PubMed
  49. J Biol Chem. 2004 Aug 6;279(32):34071-7 - PubMed
  50. Biochemistry. 2009 Jul 7;48(26):6202-12 - PubMed
  51. Nat Struct Biol. 2000 Jul;7(7):570-4 - PubMed
  52. Structure. 1998 Feb 15;6(2):233-41 - PubMed
  53. J Biomol NMR. 1995 Sep;6(2):171-9 - PubMed
  54. Methods Mol Biol. 2009;565:127-43 - PubMed
  55. J Mol Biol. 1998 Jul 3;280(1):1-9 - PubMed
  56. J Mol Biol. 2002 Dec 13;324(5):1003-14 - PubMed
  57. Biochemistry. 1996 Sep 10;35(36):11577-88 - PubMed
  58. Annu Rev Biochem. 1989;58:951-98 - PubMed
  59. Virchows Arch A Pathol Anat Histopathol. 1983;400(3):331-43 - PubMed
  60. Anal Biochem. 2004 Sep 15;332(2):261-73 - PubMed
  61. J Mol Biol. 2008 Sep 26;382(1):56-73 - PubMed
  62. Protein Sci. 1999 Sep;8(9):1743-51 - PubMed

Publication Types

Grant support